Sabaa International Company for Pharmaceutical and Chemical Industry - Laporan Laba Rugi (TTM)

Sabaa International Company for Pharmaceutical and Chemical Industry
EG ˙ CASE
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Sabaa International Company for Pharmaceutical and Chemical Industry menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 70 70 60 66 61 45 37 25 20 18 19 17 13 13 12 13 16 23 33 43
Change (%) -0.57 -14.26 9.89 -7.54 -25.27 -18.50 -31.53 -19.66 -10.63 1.85 -6.59 -26.56 4.65 -6.75 3.03 21.69 46.40 44.39 32.13
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 29 30 23 30 31 27 23 10 9 11 11 13 9 4 4 4 9 20 26 26
Change (%) 4.94 -23.22 32.05 2.88 -14.85 -15.53 -53.53 -9.32 14.70 3.86 16.58 -35.27 -58.89 4.93 2.34 131.80 128.29 31.33 0.86
% of Revenue 40.79 43.05 38.55 46.32 51.54 58.72 60.86 41.31 46.62 59.83 61.01 76.14 67.11 26.37 29.67 29.47 56.13 87.53 79.62 60.77
Gross Operating Profit 42 40 37 35 29 19 14 15 11 7 7 4 4 10 9 9 7 3 7 17
Change (%) -4.37 -7.48 -4.00 -16.53 -36.35 -22.73 2.69 -26.94 -32.74 -1.14 -42.83 1.25 134.27 -10.94 3.33 -24.31 -58.38 136.00 154.26
% of Revenue 59.21 56.95 61.45 53.68 48.46 41.28 39.14 58.69 53.38 40.17 38.99 23.86 32.89 73.63 70.33 70.53 43.87 12.47 20.38 39.23
SG&A 18 20 18 14 12 10 8 7 7 6 6 6 6 6 6 7 7 13 13 12
Change (%) 8.22 -9.33 -19.78 -18.42 -14.42 -20.47 -7.95 2.30 -22.77 8.50 1.92 -0.07 2.69 -2.82 5.30 0.82 89.66 1.72 -4.64
% of Revenue 25.68 27.96 29.56 21.58 19.04 21.80 21.28 28.60 36.42 31.47 33.52 36.58 49.77 48.84 50.90 52.02 43.09 55.83 39.33 28.38
R&D
Change (%)
% of Revenue
OpEx 52 50 41 45 43 37 30 18 17 17 18 20 15 10 10 10 15 34 40 40
Change (%) -4.91 -17.75 9.55 -3.89 -14.73 -16.86 -41.72 -4.56 -1.73 5.46 11.38 -23.85 -32.97 -0.24 4.23 48.46 118.73 19.26 -0.94
% of Revenue 74.24 71.00 68.11 67.89 70.58 80.52 82.14 69.91 83.04 91.30 94.54 112.72 116.88 74.87 80.10 81.03 98.85 147.68 121.98 91.46
Operating Income 18 20 19 21 18 9 7 8 3 2 1 -2 -2 3 2 2 0 -11 -7 4
Change (%) 11.93 -5.70 10.63 -15.26 -50.54 -25.26 15.37 -54.72 -54.17 -36.01 -317.42 -2.53 -255.83 -26.15 -1.79 -92.62 -6,165.36 -33.43 -151.34
% of Revenue 25.76 29.00 31.89 32.11 29.42 19.48 17.86 30.09 16.96 8.70 5.46 -12.72 -16.88 25.13 19.90 18.97 1.15 -47.68 -21.98 8.54
Interest Expense -1 -1 -1 -1 -1 -1 -1 -0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -2 -2
Change (%) -8.97 11.49 34.27 -0.09 -34.09 -5.59 -21.61 37.79 59.97 12.03 20.04 -10.01 -18.88 -8.11 -9.93 5.75 31.51 29.18 22.45
% of Revenue -1.04 -0.95 -1.24 -1.51 -1.63 -1.44 -1.67 -1.91 -3.27 -5.86 -6.44 -8.28 -10.15 -7.87 -7.75 -6.78 -5.89 -5.29 -4.73 -4.39
Net Income 13 15 14 16 13 7 5 6 2 0 -1 -4 -4 1 -8 -8 -10 -18 -6 5
Change (%) 12.46 -6.23 11.18 -15.80 -48.98 -25.10 17.73 -59.54 -99.25 -3,409.35 604.63 3.01 -126.56 -749.29 4.77 25.58 82.64 -64.05 -182.32
% of Revenue 19.19 21.71 23.74 24.02 21.87 14.93 13.72 23.59 11.88 0.10 -3.23 -24.40 -34.22 8.69 -60.49 -61.51 -63.48 -79.19 -19.71 12.28

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista